Reported Standalone quarterly numbers for Ipca Laboratories are:Net Sales at Rs 1,506.83 crore in December 2023 up 5.17% from Rs. 1,432.79 crore in December 2022.
Quarterly Net Profit at Rs. 136.94 crore in December 2023 up 13.86% from Rs. 120.27 crore in December 2022.
EBITDA stands at Rs. 290.38 crore in December 2023 up 21.35% from Rs. 239.29 crore in December 2022.
Ipca Labs EPS has increased to Rs. 5.40 in December 2023 from Rs. 4.74 in December 2022.
| Ipca Labs shares closed at 1,152.35 on February 15, 2024 (NSE) and has given 29.53% returns over the last 6 months and 36.61% over the last 12 months. |
| Ipca Laboratories | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'23 | Sep'23 | Dec'22 | | Net Sales/Income from operations | 1,506.83 | 1,662.67 | 1,432.79 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1,506.83 | 1,662.67 | 1,432.79 | | EXPENDITURE | | Consumption of Raw Materials | 411.25 | 485.72 | 351.07 | | Purchase of Traded Goods | 75.25 | 100.13 | 65.60 | | Increase/Decrease in Stocks | -1.11 | -50.96 | 80.99 | | Power & Fuel | -- | -- | -- | | Employees Cost | 334.33 | 336.15 | 294.81 | | Depreciation | 63.02 | 61.35 | 57.03 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 413.62 | 482.65 | 426.33 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 210.47 | 247.63 | 156.96 | | Other Income | 16.89 | 36.14 | 25.30 | | P/L Before Int., Excpt. Items & Tax | 227.36 | 283.77 | 182.26 | | Interest | 27.21 | 38.64 | 10.43 | | P/L Before Exceptional Items & Tax | 200.15 | 245.13 | 171.83 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 200.15 | 245.13 | 171.83 | | Tax | 63.21 | 83.00 | 51.56 | | P/L After Tax from Ordinary Activities | 136.94 | 162.13 | 120.27 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 136.94 | 162.13 | 120.27 | | Equity Share Capital | 25.37 | 25.37 | 25.37 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 5.40 | 6.39 | 4.74 | | Diluted EPS | 5.40 | 6.39 | 4.74 | | EPS After Extra Ordinary | | Basic EPS | 5.40 | 6.39 | 4.74 | | Diluted EPS | 5.40 | 6.39 | 4.74 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
